Granahan Investment Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Granahan Investment Management’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-154,277	Closed	-$5.01M	–	196
2023 Q2	$5.01M	Buy	154,277 +131,122	+566%	+$4.79M	0.15%	132
2023 Q1	$906K	Sell	23,155 -18,029	-44%	-$882K	0.03%	158
2022 Q4	$2.18M	Sell	41,184 -13,644	-25%	-$664K	0.07%	159
2022 Q3	$2.47M	Sell	54,828 -27,418	-33%	-$1.18M	0.08%	155
2022 Q2	$2.99M	Buy	82,246 +13,518	+20%	+$491K	0.1%	149
2022 Q1	$2.84M	Sell	68,728 -145,511	-68%	-$5.12M	0.07%	159
2021 Q4	$9.13M	Sell	214,239 -137,797	-39%	-$6.89M	0.19%	118
2021 Q3	$19.4M	Sell	352,036 -66,698	-16%	-$3.49M	0.37%	69
2021 Q2	$20M	Buy	418,734 +128,888	+44%	+$6.57M	0.37%	65
2021 Q1	$14.7M	Buy	289,846 +242,031	+506%	+$13.5M	0.31%	71
2020 Q4	$3.01M	Buy	+47,815	New	+$2.97M	0.07%	155

Other funds holding SILK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Granahan Investment Management's SILK Position: Q3 2023 in Review

Granahan Investment Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2023, closing a stake of 154,277 shares — an estimated $5.01M sold.

Granahan Investment Management first reported a position in SILK in Q4 2020 and held it in 11 quarters. The position peaked at $20M in Q2 2021. 166 funds tracked by Wall St. Rank hold SILK as of Q3 2023.

Granahan Investment Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Granahan Investment Management sold 154,277 Silk Road Medical, Inc. Common Stock shares in Q3 2023, an estimated $5.01M.
Granahan Investment Management first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
Granahan Investment Management's Silk Road Medical, Inc. Common Stock position peaked at $20M in Q2 2021.
166 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2023.

Based on Granahan Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.